Design, synthesis and evaluation of photoactivatable derivatives of microtubule (MT)-active [1,2,4]triazolo[1,5-a]pyrimidines. 2018

Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.

The [1,2,4]triazolo[1,5-a]pyrimidines comprise a promising class of non-naturally occurring microtubule (MT)-active compounds. Prior studies revealed that different triazolopyrimidine substitutions can yield molecules that either promote MT stabilization or disrupt MT integrity. These differences can have important ramifications in the therapeutic applications of triazolopyrimidines and suggest that different analogues may exhibit different binding modes within the same site or possibly interact with tubulin/MTs at alternative binding sites. To help discern these possibilities, a series of photoactivatable triazolopyrimidine congeners was designed, synthesized and evaluated in cellular assays with the goal of identifying candidate probes for photoaffinity labeling experiments. These studies led to the identification of different derivatives that incorporate a diazirine ring in the amine substituent at position 7 of the triazolopyrimidine heterocycle, resulting in molecules that either promote stabilization of MTs or disrupt MT integrity. These photoactivatable candidate probes hold promise to investigate the mode of action of MT-active triazolopyrimidines.

UI MeSH Term Description Entries
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
March 2019, European journal of medicinal chemistry,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
February 2022, Molecular diversity,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
August 2009, Chemistry & biodiversity,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
May 2012, Steroids,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
February 2021, European journal of medicinal chemistry,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
May 2007, Molecules (Basel, Switzerland),
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
December 2016, Steroids,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
May 2015, Journal of medicinal chemistry,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
January 1997, Die Pharmazie,
Killian Oukoloff, and Jane Kovalevich, and Anne-Sophie Cornec, and Yuemang Yao, and Zachary A Owyang, and Michael James, and John Q Trojanowski, and Virginia M-Y Lee, and Amos B Smith, and Kurt R Brunden, and Carlo Ballatore
January 2017, European journal of medicinal chemistry,
Copied contents to your clipboard!